These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

197 related articles for article (PubMed ID: 26770073)

  • 1. Validation of a modified thromboelastometry approach to detect changes in fibrinolytic activity.
    Kuiper GJ; Kleinegris MC; van Oerle R; Spronk HM; Lancé MD; Ten Cate H; Henskens YM
    Thromb J; 2016; 14():1. PubMed ID: 26770073
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Assessment and determinants of whole blood and plasma fibrinolysis in patients with mild bleeding symptoms.
    Vries MJA; Macrae F; Nelemans PJ; Kuiper GJAJM; Wetzels RJH; Bowman P; Verhezen PWM; Ten Cate H; Ariëns RAS; Henskens YMC
    Thromb Res; 2019 Feb; 174():88-94. PubMed ID: 30579151
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Factor XIII and tranexamic acid but not recombinant factor VIIa attenuate tissue plasminogen activator-induced hyperfibrinolysis in human whole blood.
    Dirkmann D; Görlinger K; Gisbertz C; Dusse F; Peters J
    Anesth Analg; 2012 Jun; 114(6):1182-8. PubMed ID: 22104068
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Recombinant tissue-type plasminogen activator-evoked hyperfibrinolysis is enhanced by acidosis and inhibited by hypothermia but still can be blocked by tranexamic acid.
    Dirkmann D; Radü-Berlemann J; Görlinger K; Peters J
    J Trauma Acute Care Surg; 2013 Feb; 74(2):482-8. PubMed ID: 23354242
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Validation of the time to attain maximal clot amplitude after reaching maximal clot formation velocity parameter as a measure of fibrinolysis using rotational thromboelastometry and its application in the assessment of fibrinolytic resistance in septic patients: a prospective observational study: communication from the ISTH SSC Subcommittee on Fibrinolysis.
    Scarlatescu E; Kim PY; Marchenko SP; Tomescu DR
    J Thromb Haemost; 2024 Apr; 22(4):1223-1235. PubMed ID: 38104723
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison between thrombelastography and thromboelastometry in hyperfibrinolysis detection during adult liver transplantation.
    Abuelkasem E; Lu S; Tanaka K; Planinsic R; Sakai T
    Br J Anaesth; 2016 Apr; 116(4):507-12. PubMed ID: 26934942
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Increased resistance to tissue plasminogen activator-induced fibrinolysis in healthy subjects from Thailand.
    White NJ; Taflin N; Lim EB; Akaraborworn O
    Blood Coagul Fibrinolysis; 2018 Jun; 29(4):356-360. PubMed ID: 29337700
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Experimental model of hyperfibrinolysis designed for rotational thromboelastometry in children with congenital heart disease.
    Faraoni D; Rozen L; Willems A; Torres CS; Pereira LM; Demulder A; Van der Linden P
    Blood Coagul Fibrinolysis; 2015 Apr; 26(3):290-7. PubMed ID: 25806960
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The in-vitro effect of fibrinogen, factor XIII and thrombin-activatable fibrinolysis inhibitor on clot formation and susceptibility to tissue plasminogen activator-induced fibrinolysis in hemodilution model.
    Shenkman B; Livnat T; Lubetsky A; Tamarin I; Budnik I; Einav Y; Martinowitz U
    Blood Coagul Fibrinolysis; 2012 Jul; 23(5):370-8. PubMed ID: 22498982
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Whole blood thromboelastometry profiles in women with preeclampsia.
    Spiezia L; Bogana G; Campello E; Maggiolo S; Pelizzaro E; Carbonare CD; Gervasi MT; Simioni P
    Clin Chem Lab Med; 2015 Oct; 53(11):1793-8. PubMed ID: 25803079
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparison of results obtained using clot-fibrinolysis waveform analysis and global fibrinolysis capacity assay with rotational thromboelastography.
    Tsuchida T; Hayakawa M; Kumano O
    Sci Rep; 2024 Mar; 14(1):7602. PubMed ID: 38556522
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Reference values for rotational thromboelastometry (ROTEM) in clinically healthy cats.
    Marly-Voquer C; Riond B; Jud Schefer R; Kutter AP
    J Vet Emerg Crit Care (San Antonio); 2017 Mar; 27(2):185-192. PubMed ID: 28166379
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effective tranexamic acid concentration for 95% inhibition of tissue-type plasminogen activator induced hyperfibrinolysis in children with congenital heart disease: A prospective, controlled, in-vitro study.
    Rozen L; Faraoni D; Sanchez Torres C; Willems A; Noubouossie DC; Barglazan D; Van der Linden P; Demulder A
    Eur J Anaesthesiol; 2015 Dec; 32(12):844-50. PubMed ID: 26258658
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Lysis Timer: a new sensitive tool to diagnose hyperfibrinolysis in liver transplantation.
    Roullet S; Labrouche S; Mouton C; Quinart A; Nouette-Gaulain K; Laurent C; Freyburger G
    J Clin Pathol; 2019 Jan; 72(1):58-65. PubMed ID: 30282673
    [TBL] [Abstract][Full Text] [Related]  

  • 15. ROTEM diagnostic capacity for measuring fibrinolysis in neonatal sepsis.
    Lampridou M; Sokou R; Tsantes AG; Theodoraki M; Konstantinidi A; Ioakeimidis G; Bonovas S; Politou M; Valsami S; Iliodromiti Z; Boutsikou T; Iacovidou N; Nikolopoulos G; Tsantes AE
    Thromb Res; 2020 Aug; 192():103-108. PubMed ID: 32464452
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Lysis onset time as diagnostic rotational thromboelastometry parameter for fast detection of hyperfibrinolysis.
    Dekker SE; Viersen VA; Duvekot A; de Jong M; van den Brom CE; van de Ven PM; Schober P; Boer C
    Anesthesiology; 2014 Jul; 121(1):89-97. PubMed ID: 24646494
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of remote ischaemic conditioning on coagulation and fibrinolysis.
    Kristiansen J; Grove EL; Rise N; Neergaard-Petersen S; Würtz M; Kristensen SD; Hvas AM
    Thromb Res; 2016 May; 141():129-35. PubMed ID: 27018926
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Correlations between ROTEM fibrinolytic activity and t-PA, PAI-1 levels in patients with newly diagnosed multiple myeloma].
    Misiewicz M; Robak M; Chojnowski K; Treliński J
    Pol Merkur Lekarski; 2014 May; 36(215):316-9. PubMed ID: 24964508
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Impaired Whole-Blood Fibrinolysis is a Predictor of Mortality in Intensive Care Patients.
    Brewer JS; Hvas CL; Hvas AM; Larsen JB
    TH Open; 2024 Jan; 8(1):e164-e174. PubMed ID: 38550335
    [No Abstract]   [Full Text] [Related]  

  • 20. Monitoring fibrinolysis in whole blood by viscoelastic instruments: a comparison of ROTEM and ReoRox.
    Nilsson CU; Tynngård N; Reinstrup P; Engström M
    Scand J Clin Lab Invest; 2013 Sep; 73(6):457-65. PubMed ID: 23767889
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.